A-RNA 2026 PROGRAM

Program subject to change.

A-RNA 2026 Program

Stream Colour Guide

  • A-RNA session
  • mRNA session
  • Plenary / Keynote
  • Social Events
  • Breaks / Other
  • Sponsored Symposia

Day 1 · Monday 26 October 2026

  1. 8:30 AM
    Breaks / Other

    Registration

    8:30 AM – 6:00 PMGrand Chelsea Lobby
  2. 9:45 AM
    Breaks / Other

    Opening Ceremony

    9:45 AM – 10:00 AMDaintree Room
  3. 10:00 AM
  4. 10:45 AM
    Breaks / Other

    Morning Tea / Posters / Exhibition

    10:45 AM – 11:15 AMSundown + Piper + Topaz
  5. 11:15 AM
    Presentations
    1. From genetics to potential therapeutics: Exploiting lncRNAs for breast cancer treatment
      Prof Juliet French, QIMR Berghofer, Queensland, AustraliaInvited speaker
    2. Circular RNAs in Glioblastoma and Stem Cell Differentiation: Spatial Mapping and Functions
      Prof Simon Conn, Flinders University, South Australia, AustraliaInvited speaker
    3. Non-gonadal PIWIL1/Aubergine drives regenerative and tumourigenic stem cell proliferation in the intestine
      Dr Rippei Hayashi, ANU, ACT, AustraliaInvited speaker
    4. An RNA-targeted strategy to enhance PARP inhibitor sensitivity in triple-negative breast cancer
      Xue LuOral abstract
    5. Small non-coding RNAs (sncRNAs) responses to mitochondrial genome (mtDNA) damage
      Rachel Shin Yie LeeOral abstract
    6. Engineering the initiator tRNA: understanding and manipulating the anticodon identity set
      Paul R JaschkeOral abstract

    Chair Tim Mercer

    Presentations
    1. Talk title will be confirmed shortly
      Dr Lorena Preciado-Llanes, Sanofi Vaccines, Queensland, AustraliaInvited speaker
    2. From Pandemic Response to Sovereign Capability: Why mRNA Matters for Australia’s Future
      Phoebe Dunn, mRNA Victoria, AustraliaInvited speaker
    3. Talk title to be confirmed
      Felicia Pradera, Moderna, Victoria, AustraliaInvited speaker
    4. Talk title to be confirmed
      Lorena Preciado LlanesOral abstract
    5. Genetic Medicines and Individualized Manufacturing for Everyone
      Dr John Schiel, Invited speaker
  6. 12:45 PM
    Breaks / Other

    Lunch / Posters / Exhibition

    12:45 PM – 1:45 PMSundown + Piper + Topaz
    Social Events

    EMCR Round Table Lunch Session

    12:45 PM – 1:45 PMDaintree Room
  7. 1:00 PM
    Speakers
    • Dr Sarah HerridgeDirector, Research & Scientific Affairs, BioNTech Australia
    • Dr John PowerSenior Director, Ecosystem Development & R&D Production, BioNTech Australia
    • Dr Benjamin Ward MuirAssociate Director, Ecosystem Development, BioNTech Australia
  8. 1:45 PM
    Presentations
    1. When splicing stalls: mechanisms of spliceosome quality control
      A/Prof Tamas Fischer, ANU, ACT, AustraliaInvited speaker
    2. Intronless mobile elements exploit splice donor sites to subvert the mRNA surveillance machinery
      Charles C BellOral abstract
    3. Determination of the structure and binding substrates of ESRP1 reveals multiple modes of target regulation
      Dawei LiuOral abstract
    4. m6A positions polyadenylation in Plasmodium falciparum
      Joshua M LevendisOral abstract
    5. RNA mediated regulation of facultative chromatin
      Dr Evan Healy, Monash University, Victoria, AustraliaAward winner
    6. Splice and Tell: Dissecting QKI-Regulated Alternative Splicing Networks in Prostate Cancer
      Zoe K PriceOral abstract

    Chair Ben Hughes

    Presentations
    1. Advancing Australia’s RNA Ecosystem
      Marc Fini, RNA Australia, NSW, AustraliaInvited speaker
    2. Translating mRNA into Medicines: Design, Manufacture, and Development of New mRNA-LNP Medicines
      Natasha Chaudhary, The University of Queensland, Queensland, AustraliaInvited speaker
    3. Improved Thermostability and Accessibility of mRNA Vaccines with High-Density Microarray Platform Delivery
      Deborah Pascoe, Vaxxas, Queensland, AustraliaInvited speaker
    4. Talk title to be confirmed
      Dr Olga Shimoni, The University of Western Australia (UWA), Western Australia, AustraliaInvited speaker
  9. 3:15 PM
    Breaks / Other

    Afternoon Tea / Posters / Exhibition

    3:15 PM – 3:45 PMSundown + Piper + Topaz
  10. 3:45 PM
    Presentations
    1. Mapping, functional characterization and therapeutic targeting of RNA structural ensembles in living cells
      A/Prof Danny Incarnato (online), University of Groningen, NetherlandsInvited speaker
    2. The molecular basis for CRISPR-Cas13 HEPN RNase activity
      A/Prof Gavin Knott, Monash University, Victoria, AustraliaInvited speaker
    3. RNA DCC: Harnessing an RNase for the Modular Assembly of Functional RNAs
      Jonas KaltbeitzelOral abstract
    4. Peanut Clump Virus tRNA-like Structure Hijacks Host Ribosomes for poly(A)-independent Translation
      Ye (Bruce) LiOral abstract
    5. Drugging the undruggable: how thiol reactive compounds trap mRNA in complex with NONO
      Prof Charlie Bond, University of Western Australia, Western Australia, AustraliaInvited speaker
    Presentations
    1. Establishing RNA Technologies in New Zealand
      Rebecca McKenzieOral abstract
    2. Cold-adapted Njord RNA polymerase enables in vitro transcription at reduced temperatures
      Dillon B NyeOral abstract
    3. Beyond the Template: Removing DNA Constraints from the Future of RNA
      Michael HutchinsOral abstract
    Panel discussion

    The Australian and Global mRNA Landscape

  11. 5:15 PM
  12. 6:00 PM
    Presentations
    1. Reprograming Activated Fibroblasts with Fibroblast Activation Protein-Targeted mRNA-LNPs for Cardiac Tissue Regeneration and Cancer Immunotherapy
      Dan YanOral abstract
    Posters (56)
    1. VIRMA amplification drives oncogenesis and chemoresistance in High Grade Serous Ovarian Cancer
      Stephanie AdlerPoster
    2. Barriers to Exogenous RNA-mediated Gene Silencing in Phytophthora cinnamomi
      Luciasih AgustiniPoster
    3. Dory lncRNA modulates female-specific hippocampal spatial memory
      Saba AltafPoster
    4. A histone variant establishes a novel link between chromatin and nuclear RNA decay in spermatogenesis and beyond.
      Nazmul Hasan ApuPoster
    5. Characterising the role of Z-DNA in the context of ADAR1 localisation and functionality in Alzheimer’s disease
      Gabriel John AranetaPoster
    6. Functional and Epitranscriptomic Characterisation of Phage-Encoded tRNAs
      Sanila AsadPoster
    7. Targeted RNA Capture-Seq enables splicing assessment of lowly expressed Mendelian disease genes from accessible tissues
      Lachlan BaerPoster
    8. Lipid nanoparticles enable high-efficiency CRISPR HDR-mediated gene insertions in primary human T cells
      Jagan BillakantiPoster
    9. Freeze-Drying Improves the Stability of Unencapsulated mRNA
      Tim BilbroughPoster
    10. Hidden Genes: New Technologies for Functional Annotation of Long Noncoding RNAs in Cancer
      Maina BitarPoster
    11. CoZyCapTM T7 RNA Polymerase: an enzymatic solution for efficient co-transcriptional capping
      Jenny BrownPoster
    12. A Group I Intron Reporter Reveals a Novel RNA Quality Control Pathway in Mammalian Cells
      Lachlan BullmanPoster
    13. Isolation of Protein Corona on mRNA Lipid Nanoparticles for Spleen-Targeted Cancer Vaccination
      Ella BurdettPoster
    14. Investigating the regulatory roles of microRNA clusters in neuroblastoma development
      Regina Belen P CallantaPoster
    15. A pseudo-longitudinal single-cell framework uncovers ovarian lncRNAs linked to cancer emergence and chemoresistance
      Larissa CassianoPoster
    16. Connecting long noncoding RNAs to drug response in high-grade serous ovarian cancer
      Shenyu ChenPoster
    17. Inhibition of KRAS by steric-blocking 2′-O-methyl phosphorothioate RNA antisense oligonucleotides
      Suxiang ChenPoster
    18. Cellulose Nanocrystals as a Biodegradable Nanoparticle Platform for siRNA Delivery and Gene Silencing in Plants
      Tal CooperPoster
    19. Development of a Patient-Specific Splice-Switching Antisense Oligonucleotide for SLC6A1 Neurodevelopmental Disorder
      Laura CroftPoster
    20. Long noncoding RNAs in the etiology of brain disorders and complex traits
      Mitchell CumminsPoster
    21. New Zealand’s RNA Platform and the Development of Novel Ionizable Lipids
      Gabriella DaveyPoster
    22. Beyond COVID-19: Building Scalable RNA Manufacturing for Australia's Future
      Peter DavisPoster
    23. Can TLR2/6 stimulation Enhance mRNA vaccine Immunogenicity?
      Ellie DoubledayPoster
    24. Mapping Tumor-Intrinsic 5'UTR Structural Vulnerabilities for Selective mRNA Therapeutics
      Nsisong EkongPoster
    25. PROFILING RNA STRUCTURAL HETEROGENEITY IN Arabidopsis thaliana
      Putri Adiela Agson GaniPoster
    26. A Framework-Based Systematic Review for Qualifying Circulating RNA Biomarker Evidence: A Case Study in Age-Related Macular Degeneration
      Tadele GashayiePoster
    27. Bridging structure and function of RNA through the lens of structural modules
      Rowan J HeggenPoster
    28. Uncovering New Mechanisms That Restrain Innate Sensing of Self Double-Stranded RNA
      Jacki E Heraud-FarlowPoster
    29. A modular platform for site-specific epitranscriptomic analysis using mass spectrometry
      Enzo HuangPoster
    30. UPF3A and UPF3B shape the transcriptome cooperatively through nonsense mediated mRNA decay yet oppose cell function
      Lachlan A JollyPoster
    31. Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen
      Joanna KuangPoster
    32. Dicodon organization links tRNA modifications to cancer cell proteome
      Eric P KusnadiPoster
    33. mRNA reference standards to evaluate the design, manufacture and performance of mRNA medicines.
      Salina TondwalkarPoster
    34. Using self-amplifying RNA to deliver antiviral gene silencing
      Scott LedgerPoster
    35. Exploiting a Conserved Ligand-Binding Mode to Overcome cfr-Mediated Ribosomal Resistance
      Ye (Bruce) LiPoster
    36. Multidimensional high-throughput screening and regulatory mechanism analysis of functional elements in human genome-wide mRNA 3’UTR
      Yuanyuan LiPoster
    37. Functional role of m6A-RNA methylation in the regulation of neural network and memory assembly
      Yajing LinPoster
    38. A conserved RNA methyltransferase plays a key role in the regulation of arginine uptake by the intracellular parasite Toxoplasma gondii.
      Victor V MakotaPoster
    39. Adaptive Integration of Heterogeneous Foundation Models to Find Histologically Predictable Genes in Breast Cancer
      Hao NguyenPoster
    40. The RNA Development Platform: Building RNA Capability in Aotearoa New Zealand
      Catrin OgilviePoster
    41. Insights into Transposable Element taming in Austropuccinia psidii
      Sebastian N Orellana-QuinterosPoster
    42. Seed delivered dual-action RNAi for insect control and modified plant traits
      Soumitra PatekarPoster
    43. Sustained Analgesia by Modulation of Synaptic Vesicle Endocytosis in Nociceptors Using a dCas9 Repression Strategy
      Thomas J. PaynePoster
    44. Harnessing a Fuligo septica catalytic RNA as the basis of a molecular switch
      Angus PeadyPoster
    45. Development and validation of a Self-Amplifying RNA platform
      Yi PengPoster
    46. Development of novel circRNA liquid biopsy biomarkers for mesothelioma diagnosis
      Emma RathPoster
    47. An Integrated Design–Build–Test Workflow for Computational Engineering and Functional Validation of Synthetic mRNAs
      Agin RavindranPoster
    48. Investigating Paternal Epigenetic Inheritance via small non-coding RNA: Intergenerational effects of Paternal Immune Activation
      Sonali N ReisingerPoster
    49. Programmable Translation Using Engineered tRNAs
      Natalie K RobertsPoster
    50. T2G: A high-performance transcriptome-to-genome BAM coordinate converter supporting both short and long-read RNA sequencing.
      Danielle L RudlerPoster
    51. Convergent, program-specific cis-regulation shapes the multi-layer translational response of starved yeast
      Nikolay ShirokikhPoster
    52. Optimising mRNA Design by Rethinking UTR Structural Constraints
      Tessa SwainPoster
    53. The Long and Short of It: Novel Transcript Discovery in Melanoma Using Nanopore Long-read RNA Sequencing
      Jun Yao TeowPoster
    54. Understanding the molecular grammar of RNA interactions
      Pall ThordarsonPoster
    55. Investigating the biodistribution of morpholino oligomers in the central nervous system of mice
      Vanja TodorovskiPoster
    56. Behavioural Phenotyping of Adar1-Editing Deficient and Adar1/Adar2 Compound-Editing Deficient Mice.
      Carl WalkleyPoster

Day 2 · Tuesday 27 October 2026

  1. 8:30 AM
    Breaks / Other

    Registration

    8:30 AM – 5:00 PMGrand Chelsea Lobby
  2. 9:15 AM
  3. 10:00 AM
    Breaks / Other

    Morning Tea / Posters / Exhibition

    10:00 AM – 10:25 AMSundown + Piper + Topaz
  4. 10:30 AM
    Presentations
    1. Talk title will be confirmed shortly
      A/Prof Quan Nguyen, QIMRB National Centre for Spatial Tissue and AI Research (NCSTAR), Queensland, AustraliaInvited speaker
    2. Resolving Isoform-Level Transcriptomic Complexity in Single Cells
      A/Prof Ulf Schmitz, James Cook University, Queensland, AustraliaInvited speaker
    3. Reading between the exons: new methods for novel transcript discovery
      Dr Nadia Davidson, Walter and Eliza Hall Institute, Victoria, AustraliaInvited speaker
    4. VX: a desktop transcriptome browser with agent control for direct RNA sequencing and nucleotide modifications
      Nikolay ShirokikhOral abstract
    5. Epitranscriptome language modelling is enabled by domain-informed vocabulary expansion with limited data
      Alexandra SneddonOral abstract
    6. Identification of Breast Cancer-Associated lncRNAs Using 3D and In Vivo CRISPR-Cas13d Screen
      Lu WangOral abstract

    Chair Brandon Wainwright

    Presentations
    1. Engineering Precision mRNA Lipid Nanoparticles: From AI-Driven Lipid Discovery to Precision Cancer Immunotherapy
      Prof Chun-Xia Zhao, Adelaide University, Adelaide, AustraliaInvited speaker
    2. Engineering Lipid Nanoparticles for mRNA Delivery: Lessons from Vaccines, Applications in Therapy
      Dr Yi (David) Ju, Olivia Newton-John Cancer Research Institute (ONJCRI), La Trobe University, Victoria, AustraliaInvited speaker
    3. A folate-targeted RNA therapeutic strategy for CEP55 silencing in metastatic triple-negative breast cancer models
      Ben BR RashidiehOral abstract
    4. Advancing mRNA Vaccines and Cytokine Therapies for Cancer
      Liam O'BrienOral abstract
  5. 12:00 PM
    Breaks / Other

    Lunch / Posters / Exhibition

    12:00 PM – 1:00 PMSundown + Piper + Topaz
  6. 12:15 PM
    Speakers
    • Dr Doug HortonPrincipal, Spruson & Ferguson
    • Dr Jay RasmussenAssociate, Spruson & Ferguson
    • Dr Abrey YeoAssociate, Spruson & Ferguson

    Unlocking mRNA’s Full Potential: From LNP Encapsulation to Purification and Formulation

    Robust encapsulation of mRNA in lipid nanoparticles (LNPs) is a critical area of development and differentiation in the rapidly evolving field of RNA–LNP therapeutics. A central challenge is translating promising benchtop results into scalable, reproducible manufacturing processes that meet GMP requirements. Sartorius offers a broad portfolio of scale-appropriate solutions to support this transition across the mRNA–LNP workflow. In this workshop, we will present approaches for mRNA encapsulation, downstream purification, and final formulation of mRNA–LNP products. We will discuss how integrated solutions can help streamline process development, facilitate scale-up, and support consistent product quality from early research through GMP manufacturing. The session will also introduce emerging approaches for mRNA–LNP analytics, supporting process understanding and informed decision-making throughout development. Join us to explore how Sartorius can help accelerate the path from benchtop innovation to robust, scalable mRNA–LNP production.

    Speakers
    • Blaz BakarlaBusiness Development Manager
    • Richard ZhuCommercial Development Manager
  7. 1:00 PM
    Presentations
    1. LncRNA in the regulation of complex behaviour
      A/Prof Kelly Clemens, UNSW, NSW, AustraliaInvited speaker
    2. Small non-coding RNAs regulate cell-autonomous and intercellular propagation of mitochondrial stress signals
      Prof Steven Zuryn, Queensland Brain Institute, The University of Queensland, Queensland, AustraliaInvited speaker
    3. Uncovering the role of chromatin regulator ZMYND8 in brain development using human organoid models
      Dr Nicole Green, UNSW, NSW, AustraliaInvited speaker
    4. Light-inducible proximity labelling in vivo captures sex-specific RNA at excitatory synapses
      Paul R MarshallOral abstract
    5. What’s in a Message? Long-Read RNA Sequencing Reveals Convergent RNA Regulatory and Axonal Pathways in Distal Hereditary Motor Neuropathy.
      Madison D.V. GonebaleOral abstract
    6. Divergent pathologies in ALS are associated with distinct gene expression, splicing, and intron retention profiles.
      Gavin SuttonOral abstract

    Chair Yi (David) Ju

    Presentations
    1. Talk title will be confirmed shortly
      Dr Liam O'Brien, Australian Institute of Bioengineering and Nanotechnology (AIBN), University of Queensland, Queensland, AustraliaInvited speaker
    2. Optimising an mRNA/LNP approach to treating paediatric brain cancer
      Prof Brandon Wainwright, Frazer Institute, University of Queensland, Queensland, AustraliaInvited speaker
    3. Transient by design: mRNA-encoded CARs for NK cell-based immunotherapy
      A/Prof Fernando Guimaraes, Frazer Institute, The University of Queensland, Queensland, AustraliaInvited speaker
    4. Flavivirus-based self amplifying RNA for vaccines and therapeutics
      Dr Chris McMillan, School of Chemistry and Molecular Biosciences, University of Queensland, Queensland, AustraliaInvited speaker
    5. Post-Loaded Lipid Nanoparticles for On-Demand RNA Delivery
      Sarah DraperOral abstract
  8. 2:30 PM
    Breaks / Other

    Afternoon Tea / Posters / Exhibition

    2:30 PM – 3:00 PMSundown + Piper + Topaz
  9. 3:00 PM
    Presentations
    1. Developing ultra short RNAs therapeutics for autoimmunity
      Prof Michael Gantier, Hudson Institute, Victoria, AustraliaInvited speaker
    2. RNA sensing during human influenza A virus infection: challenging established paradigms
      Dr Larisa Labzin, Institute for Molecular Bioscience, University of Queensland, Queensland, AustraliaInvited speaker
    3. Leveraging lessons from small RNAs to program RNA cleavage in bacteria with clipmers
      A/Prof Jai Tree, UNSW, NSW, AustraliaInvited speaker
    4. Defective interfering RNA induces innate immunity and broad-spectrum antiviral activity
      Min-Hsuan LinOral abstract
    5. SOF-SKN, A TOPICAL OLIGONUCLEOTIDE TOLL-LIKE RECEPTOR 7/8 INHIBITOR: RESULTS FROM A FIRST-IN-HUMAN PHASE 1A/B STUDY
      Olivier F LaczkaOral abstract
    6. RNAte: Australia's First NATA-Accredited Platform for RNA Product Innate Immune Testing
      Tony S CardnoOral abstract

    Chair Felicia Pradera

    Presentations
    1. National Critical Research Infrastructure for Antisense Therapy Development
      May Aung-Htut, Murdoch University, Western Australia, AustraliaInvited speaker
    2. An Engineered MHC-I Ectodomain Shedding Strategy for Authentic Neoantigen Discovery and Personalized mRNA Cancer Vaccine Development
      Yuanyuan LiOral abstract
    3. IL-22 mRNA Therapeutics Restore Immune Tolerance to β-Cells in Type 1 Diabetes
      Prof Sumaira Hasnain, The University of Queensland, Brisbane, AustraliaInvited speaker
    4. Packaged CRISPR lipid nanoparticles as a research tool and treatment modality for cardiometabolic disease
      Michael F KeatingOral abstract
  10. 4:30 PM
  11. 5:15 PM
    A-RNA session

    A-RNA AGM (Members Only)

    5:15 PM – 6:15 PMDaintree Room
  12. 7:00 PM
    Social Events

    Conference Dinner

    7:00 PM – 10:00 PMThe Long Room, Customs House

Day 3 · Wednesday 28 October 2026

  1. 8:45 AM
    Breaks / Other

    Registration

    8:45 AM – 3:00 PMGrand Chelsea Lobby
  2. 9:15 AM
    Plenary / Keynote

    Technology Keynote

    Prof Prashant Mali, University of California San Diego (USA)Invited speaker

    9:15 AM – 10:00 AMDaintree Room
  3. 10:00 AM
    Breaks / Other

    Morning Tea

    10:00 AM – 10:25 AMSundown + Piper + Topaz
  4. 10:30 AM
    Presentations
    1. Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network
      A/Prof Phil Gregory, Adelaide University, South Australia, AustraliaInvited speaker
    2. Investigating the role of mRNA transcript diversity in melanoma progression and therapy resistance.
      Dr Lorey Smith, Peter MacCallum Cancer Centre, Victoria, AustraliaInvited speaker
    3. Preclinical Development of a Novel Morpholino Oligomer for Treating C9ORF72-Linked MND/ALS
      Dr Ianthe Pitout, The Personalised Medicine Centre, Murdoch University, Western Australia, AustraliaInvited speaker
    4. ZCCHC24 a novel stress granule-associated RNA-binding protein that regulates breast cancer cell plasticity and metastasis
      Michael OrtizOral abstract
    5. Lost in Translation: Flavivirus infection and the production of tRNA halves
      Lachlan De HayrOral abstract
    6. Modulating eIF5A-dependent mRNA translation to target cancer stem cells
      Heloisa Helena H MilioliOral abstract

    Chair Natasha Chaudhary

    Presentations
    1. Exploring the biological fate of clinical and novel mRNA-lipid nanoparticle delivery systems
      Emily Pilkington, Monash University, Victoria, AustraliaInvited speaker
    2. Engineering Lipid Nanoparticles for mRNA-based Cancer and Cancer Immunotherpies
      Dr Hao Song, Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Queensland, AustraliaInvited speaker
    3. The Mac-LNP platform: Enabling precise delivery of RNA therapeutics to disease-driving macrophage populations in vivo
      Jan SchaeferOral abstract
    4. Rapid Cell-Free DNA Template Manufacturing for Personalised mRNA Medicines
      Jonathan PetersOral abstract
  5. 12:00 PM
    Breaks / Other

    Lunch

    12:00 PM – 12:40 PMSundown + Piper + Topaz
  6. 12:45 PM
    Presentations
    1. Adapting RNA therapeutics beyond model organisms
      Dr Jochem Vink, Victoria University of Wellington, New ZealandInvited speaker
    2. Optimising cellular uptake and functionality of exogenously applied RNAi for plant protection and trait modification
      Dr Chris Brosnan, QAAFI, University of Queensland, Queensland, AustraliaInvited speaker
    3. A broad-host-range fungal pathogen deploys small RNAs that hijack host AGO1 to silence plant immunity genes
      Dr Toby Newman, Curtin University, ACT, AustraliaInvited speaker
    4. From Target Discovery to Field-Ready Delivery: An Integrated RNAi Pipeline for Control of the Australian Sheep Blowfly (Lucilia cuprina)
      Karishma T ModyOral abstract
    5. Structural Conservation of Long Non-Coding RNAs Across the Brassicaceae
      Selene L Fernandez-ValverdeOral abstract
    6. Host-induced gene silencing confers plant resistance to the fungal pathogen Verticillium dahliae
      Sidra AnwarOral abstract

    Chair Olga Shimoni

    Presentations
    1. Decoding the temporal landscape of mRNA modifications at single-molecule resolution
      Eduardo EyrasOral abstract
    2. mRNArchitect: a toolkit for the design of mRNA sequences
      Dr Helen Gunter, BASE mRNA, Queensland, AustraliaInvited speaker
    3. Programmable RNA-Dependent Splicing Activation via Engineered Group I Ribozymes
      Zana Karimi KurdistaniOral abstract
    4. Single-step isothermal synthesis of mRNA medicines
      Theodore TL LeonardOral abstract
  7. 2:15 PM
    Breaks / Other

    Afternoon Tea

    2:15 PM – 2:30 PMSundown + Piper + Topaz
  8. 2:35 PM
  9. 3:05 PM
Program current as of 15 September 2026 and subject to change. Times are Australian Eastern Standard Time (Brisbane).